Providing integrated drug discovery services to pharma, biotechnology companies and academic institutions. Read more
- About Selcia
- Drug Discovery
- Chemistry & Analytics
- News & Events
- Contact Us
Selcia scientists have determined the absolute stereochemistry of the structure of teixobactin, a novel antibacterial macrocyclic peptide whose discovery is described in a recent article published in the journal Nature by NovoBiotic Pharmaceuticals.
An initiative is under way to develop new drugs for a devastating tropical disease that threatens almost 70 million people in Africa.
Selcia Limited, the international life sciences CRO, has announced a successful inspection of its GMP radiochemistry facility by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA).